
A research center has enrolled its first patient in a phase 3 clinical trial that uses a person’s own kidney cancer cells to make a vaccine tailored to kill those cells.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ieEuhrH14pE/150420084547.htm
A research center has enrolled its first patient in a phase 3 clinical trial that uses a person’s own kidney cancer cells to make a vaccine tailored to kill those cells.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ieEuhrH14pE/150420084547.htm